UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029726
Receipt number R000033963
Scientific Title Effect of autologous formalin-fixed tumor vaccine on bone-metastatic breast cancer - A retrospective study
Date of disclosure of the study information 2017/10/30
Last modified on 2024/09/16 16:36:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of autologous formalin-fixed tumor vaccine on bone-metastatic breast cancer - A retrospective study

Acronym

Autologous formalin-fixed tumor vaccine on bone-metastatic breast cancer

Scientific Title

Effect of autologous formalin-fixed tumor vaccine on bone-metastatic breast cancer - A retrospective study

Scientific Title:Acronym

Autologous formalin-fixed tumor vaccine on bone-metastatic breast cancer

Region

Japan


Condition

Condition

Bone-metastatic breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Description of an overall survival curve on bone-metastatic breast cancer patients treated with autologous formalin-fixed tumor vaccine.

Basic objectives2

Others

Basic objectives -Others

No description has been published on the overall survival curve of tumor-vaccine-treated bone-metastatic breast cancer patients.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall survival time (from the date of initial diagnosis of bone metastasis to the date of death)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Adjuvant treatment with autologous formalin-fixed tumor vaccine on routine medical care. 3-6 intradermal injections for 6-12 weeks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

- Patients whose primary lesion of the breast cancer has been resected before or at the first diagnosis of bone metastasis and who desired adjuvant treatment with AFTV on their own expense.
- Outpatient

Key exclusion criteria

None

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Fumito
Middle name
Last name Kuranishi

Organization

Innoshima-Ishikai Hospital

Division name

Department of Surgery

Zip code

722-2211

Address

Innoshima, Onomichi, Hiroshima 722-2211, Japan

TEL

0845-24-1210

Email

ishikai@beach.ocn.ne.jp


Public contact

Name of contact person

1st name Tadao
Middle name
Last name Ohno

Organization

Cell-Medicine, Inc.

Division name

Headquarter

Zip code

305-0047

Address

2-1-6 Sengen, Tsukuba, Ibaraki 305-0074, Japan

TEL

029-828-5591

Homepage URL


Email

tad-ohno@cell-medicine.com


Sponsor or person

Institute

Innoshima-Ishikai Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB, Innoshima-Ishikai Hospital

Address

Innoshima, Onomichi, Hiroshima 722-2211, Japan

Tel

0845-24-1210

Email

ishikai@beach.ocn.ne.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

因島医師会病院(広島県)   Innoshima-Ishikai Hospital (Hiroshima)


Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 30 Day


Related information

URL releasing protocol

https://doi.org/10.1155/2018/4879406

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.1155/2018/4879406

Number of participants that the trial has enrolled

20

Results

In a retrospective analysis, three bone-metastatic breast cancer patients show clinical complete remission who received various treatments, including autologous formalin-fixed tumor vaccine therapy.

Results date posted

2024 Year 09 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Breast cancer patients of Onomichi General Hospital and Innoshima-Ishikai Hospital.

Participant flow

There is no effective treatment for breast cancer with bone metastasis. In a retrospective analysis, we identified three cases of clinical complete remission (cCR) and long survival among patients with bone metastasis who received various treatments, including autologous formalin-fixed tumor vaccine (AFTV) therapy.

Adverse events

All adverse events were less than CTCAE grade 3.

Outcome measures

Overall survival after the bone metastasis

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2004 Year 10 Month 01 Day

Date of IRB

2004 Year 04 Month 24 Day

Anticipated trial start date

2004 Year 10 Month 14 Day

Last follow-up date

2017 Year 08 Month 26 Day

Date of closure to data entry

2017 Year 09 Month 26 Day

Date trial data considered complete

2017 Year 09 Month 26 Day

Date analysis concluded

2017 Year 09 Month 26 Day


Other

Other related information



Management information

Registered date

2017 Year 10 Month 26 Day

Last modified on

2024 Year 09 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033963


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name